Search Results 241-250 of 17171 for Birth Control Evolution

  1. A Follow-up Study To Test Long-term Treatment With Nerandomilast In People With Pulmonary Fibrosis Who Took Part In A Previous Study With Nerandomilast - Mayo Clinic

    ... birth control per ICH M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly. WOCBP taking oral contraceptives ...

  2. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

    ... contraceptives are also used; all subjects of reproductive potential must agree to use both a barrier method and a second method of birth control during the ...

  3. Treatment Resistant Depression Subcallosal Cingulate Network - Mayo Clinic

    ... Contraceptive Ring (> 91%). The form of birth control will be documented at screening and baseline, as per site standard practice. Able to comply with all ...

  4. A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations - Mayo Clinic

    A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous ...

  5. A Study to Evaluate 4DCT Controls - Clinical Trials

    The purpose of this study is to assess healthy controls without any history of wrist injury or diseases by using 4DCT scanning during wrist movement to ...

  6. rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2 - Mayo Clinic

    This research proposal aims to better understand the neurobiology of depression in adolescents and how repetitive transcranial magnetic stimulation (rTMS) may ...

  7. Medical Research & Education - Mayo Clinic News Network

    Researchers Clarify Why Measles Doesn't Evolve to Escape Immunity featured image · What studies show about pregnancy, COVID-19 vaccines featured image · Science ...

  8. Medical Research & Education - Mayo Clinic News Network

    How contact tracing has evolved and ways to get through the next COVID-19 wave. DeeDee Stiepan. November 2, 2020. Biotherapeutics.

  9. A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) - Mayo Clinic

    The blinded phase only will be described in this record. Participants will receive 1 of 2 doses of GWP42003-P or matching placebo. The primary clinical ...

  10. Medical Research & Education - Mayo Clinic News Network

    August 2, 2023. 2023 Gerstner Awardee's 'evolutionary therapy' targets pancreatic cancer treatment resistance featured image. Research. 2023 Gerstner Awardee's ...